PICOFLO POWDER FOR SOLUTION

Riik: Kanada

keel: inglise

Allikas: Health Canada

Osta kohe

Laadi alla Toote omadused (SPC)
10-05-2013

Toimeaine:

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

Saadav alates:

PHARMASCIENCE INC

ATC kood:

A06AB58

INN (Rahvusvaheline Nimetus):

SODIUM PICOSULFATE, COMBINATIONS

Annus:

12G; 3.5G; 10MG

Ravimvorm:

POWDER FOR SOLUTION

Koostis:

CITRIC ACID 12G; MAGNESIUM OXIDE 3.5G; SODIUM PICOSULFATE 10MG

Manustamisviis:

ORAL

Ühikuid pakis:

2X16.1G

Retsepti tüüp:

Ethical

Terapeutiline ala:

CATHARTICS AND LAXATIVES

Toote kokkuvõte:

Active ingredient group (AIG) number: 0350181002; AHFS:

Volitamisolek:

APPROVED

Loa andmise kuupäev:

2011-07-19

Toote omadused

                                PRESCRIBING INFORMATION
PICOFLO
TM
Magnesium Oxide, Citric Acid and Sodium Picosulfate
Powder for Oral Solution
3.5 g, 12 g and 10 mg per sachet
PURGATIVE
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
Date of Revision:
May 7, 2013
CONTROL NUMBER: 162683
PicoFLO
TM
is a trademark of PHARMASCIENCE Inc.
_ _
_PicoFLO_
_TM_
_ Prescribing Information _
_Page 2 of 16_
TABLE OF CONTENTS
HEALTH PROFESSIONAL
INFORMATION..........................................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................4
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
....................................................................................................8
DOSAGE AND ADMINISTRATION
................................................................................9
OVERDOSAGE
................................................................................................................11
ACTION AND CLINICAL PHARMACOLOGY
............................................................12
STORAGE AND STABILITY
..........................................................................................12
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................12
CONSUMER INFORMATION
.................................................................................................13
_ _
_PicoFLO_
_TM_
_ Prescribing Information _
_Page 3 of 16_
PICOFLO
TM
Magnesium Oxide, Citric Acid and Sodium Picosulfate
Powder for Oral Solution
Purgative
HEALTH PROFESSIONAL INFORMATION
SUMM
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Toote omadused Toote omadused prantsuse 07-05-2013